Skip to main content
. 2017 Feb 8;58(2):117–126. doi: 10.4111/icu.2017.58.2.117

Table 1. Comparison of baseline parameters between control and BPH patients.

Variable Control (n=22) BPH (n=45) p-value
Age (y) 64.2±5.5 66.1±8.2 0.48
PSA (ng/dL) 1.5±0.6 5.7±7.4 0.06
Serum hormone concentration
 Estradiol (pg/dL) 22.4±8.8 27.9±11.1 0.13
 Testosterone (ng/dL) 394.8±193.8 350.6±129.0 0.37
 Estradiol/testosterone ratio 0.08±0.07 0.1±0.05 0.25
Prostate size (g) 19.4±4.8 46.1±15.5 <0.001
Baseline urine flow
 PVR (mL) 10.5±15.5 121.0±113.6 0.004
 Qmax (mL/s) 15.9±3.9 7.7±3.3 <0.001

Values are presented as mean±standard deviation.

BPH, benign prostatic hyperplasia; PSA, prostate-specific antigen; Qmax, maximal flow rate.